DRDO developing oxygen cylinders to meet COVID needs: Chairman
The Hindu
‘It has contributed 350 technologies to various sectors during the last one year’
The Defence Research and Development Organisation (DRDO) hit the headlines two months ago when the Drugs Controller General of India (DCGI) approved anti-COVID oral drug, 2-deoxy-D-glucose (2-DG), developed by it. Having transferred many technologies to the industry sector in general and healthcare in particular during the pandemic, the DRDO has now geared up to supply small oxygen cylinders to the patients in the event of the third wave of coronavirus pandemic, apart from manufacturing 2-DG drug in a massive way. Speaking to The Hindu, DRDO G. Satheesh Reddy says that the DRDO contributed 350 technologies to the industry during the last one year.We all remember the childhood history classes on human evolution, which taught us how where men started hunting their food and learned to cook on fire create a fire that paved the way for our culinary adventures across centuries. Humans have evolved since then, wood fires have been replaced by ovens and gas stoves whereas open-fire cooking has only been a part of our backyard activity that gets a pick occasionally during special occasions.
Bengaluru and its civic bodies are notorious for delays in completion of infrastructural projects. Arguably the most infamous among such projects is the Ejipura flyover, which has been dragging on for the past seven years. Intended to connect the southeast part of the city to its east and west regions, it has faced numerous delays since its commencement in 2017.